Therapeutics

Nurse attending to pregnant woman

Accelerating the study of new drugs for HIV in pregnant and breastfeeding women: A call to action

December 9, 2021

More than 19 million women are living with HIV worldwide and the majority are of childbearing potential. There is a public health imperative to ensure that these women can make informed choices about the drugs they take for HIV treatment or prevention. Information to support optimal antiretroviral drug choices in pregnancy has rarely been available for women or their health providers, largely due to historically protectionist and conservative approaches to clinical studies conducted in pregnant and breastfeeding women.
...

Read more about Accelerating the study of new drugs for HIV in pregnant and breastfeeding women: A call to action
NIH-funded T32 Research Training Funds

Accepting nominations for **RESEARCH TRAINING FUNDS AVAILABLE FOR JUNE/JULY 2022**

December 8, 2021

NIH-funded T32 Research Training Funds to Massachusetts General Hospital, Brigham and Women’s Hospital, Harvard Medical School, Harvard T.H. Chan School of Public Health, Beth Israel Deaconess Medical Center, and Boston Children’s Hospital with funding slots available beginning June 1 and July 1, 2022.

...

Read more about Accepting nominations for **RESEARCH TRAINING FUNDS AVAILABLE FOR JUNE/JULY 2022**
National Gay Men’s HIV/AIDS Awareness Day – September 27

September 27 was National Gay Men’s HIV/AIDS Awareness Day (NGMHAAD)

September 24, 2021

National Gay Men’s HIV/AIDS Awareness Day (NGMHAAD) is observed each year on September 27 to raise awareness about the impact of HIV on gay and bisexual men in the United States.

As part of the national Ending the HIV Epidemic in the U.S. initiative, the Let’s Stop HIV Together campaign aims to empower communities, partners, and healthcare providers to promote testing, ...

Read more about September 27 was National Gay Men’s HIV/AIDS Awareness Day (NGMHAAD)
OMH logo

HIV Challenge: Innovative Community Engagement Strategies to Reduce HIV-Related Stigma and Disparities

August 12, 2021

In partnership with the Office of the Assistant Secretary for Health (OASH) Office of Infectious Disease and HIV/AIDS Policy (OIDP), the Office of Minority Health (OMH) is seeking innovative and effective approaches to improve pre-exposure prophylaxis (PrEP) medication and antiretroviral therapy (ART) utilization among racial and ethnical minority individuals who are at increased risk for HIV infection or are people with HIV (PWH)....

Read more about HIV Challenge: Innovative Community Engagement Strategies to Reduce HIV-Related Stigma and Disparities
George Seage

George R. Seage, III Pediatric HIV/AIDS Cohort Study (PHACS) Early Career Investigator Mentored Research Award Program Application

July 26, 2021

Applications for the 2021 George R. Seage III PHACS Early Career Investigator Mentored Research Award are now open and due by August 16, 2021!

Dr. George Seage was a beloved Professor of Epidemiology at the Harvard T. H. Chan School of Public Health and one of the founding members of the PHACS network. George was a passionate advocate for research on HIV prevention and treatment using novel epidemiologic methods, and was a deeply committed mentor to many early career investigators, in PHACS and beyond. The PHACS Early Career Investigator Award...

Read more about George R. Seage, III Pediatric HIV/AIDS Cohort Study (PHACS) Early Career Investigator Mentored Research Award Program Application
HU CFAR Grand Rounds : Cutting Edge Solutions in HIV Research

HU CFAR Grand Rounds video recordings

June 8, 2021

The Harvard University Center for AIDS Research virtual Grand Rounds series represents an opportunity for Harvard-affiliated HIV researchers and their collaborators to learn about and share high impact, cutting-edge research to the HU CFAR community. If you’re interested in presenting at a future webinar, suggest a topic, or learn more about it, please contact Mark Ingaciola at ...

Read more about HU CFAR Grand Rounds video recordings

PAR-21-070: Detection of HIV for Self-Testing (R61/R33 Clinical Trial Not Allowed)

November 20, 2020

AIDS Application Due Dates:  March 17, 2021; March 17, 2022; March 17, 2023

See full details: Detection of HIV for Self-Testing (R61/R33 Clinical Trial Not Allowed)

Purpose: to support innovative, collaborative, interdisciplinary early-stage research to inform the development of innovative rapid, sensitive, simple, and cost-effective...

Read more about PAR-21-070: Detection of HIV for Self-Testing (R61/R33 Clinical Trial Not Allowed)
NIH logo

NIH Funding Opportunity Announcement (FOA)

June 10, 2019

Novel RNAs in Virology (including HIV) and Immune Regulation: Basic Science and Therapeutic Discovery (R21 Clinical Trial Not Allowed)

The purpose of this Funding Opportunity Announcement (FOA) is to support basic science research, from early exploratory studies to therapeutic discovery and development, in novel biologically active viral and/or host RNAs involved in virology (including HIV biology) and immune regulation.

...

Read more about NIH Funding Opportunity Announcement (FOA)

Pages